Global Innovation
Clinical Resources FAQ   Q. How do I apply for an educational grant?
A . Educational grant requests can be made by visiting this website.Click on Educational Grants.Before applying, read about the application process.

Q. Can I save a request in progress and return to it later?
A. No. The system will not save your request. You have 60 minutes to complete your application request before the system times out. Please have all information ready and required documents available to submit as attachments before you begin the online application process. Incomplete submissions will be denied, and you will have to resubmit the entire request.

Q. What can I expect when my request is submitted through the website?
A. Once you submit your request, the system will provide you with a Grant ID number. Please keep this Grant ID number handy.

Q. How can I check the status of my grant request?
A. You can check the status of your grant request at any time on the website by clicking Check Application Status, using the Grant ID number and your email address. Keep in mind that the Educational Grants Committee meets once a month to review requests. Most likely you will not see any status updates in the system for at least 3-4 weeks from the time you submitted your request.

Q. What is the timeframe for submitting an educational grant request?
A. All requests must be received at least 60 days prior to the date of the program/event.

Q. How long will the approval of my grant request take?
A. The Educational Grants Committee meets once a month to review all grant requests. You will be notified of the Committee's decision. If your request is approved, a Letter of Agreement (LOA) will be sent to your attention. The LOA must be signed by both parties before the funding process begins.

Q. I submitted all necessary documents and information weeks ahead of the required 60 days. Why did my request get denied?
A. An institution must, at a minimum, meet the requirements outlined in our Educational Grants Guidelines. Please note that meeting these requirements and submitting a request in a timely manner does not automatically ensure approval of a grant. We award educational grants at our sole discretion, based on factors that include budget availability and alignment with the company's area of interests.

Q. Can I fax or mail in my request?
A. No. All educational grant requests must be submitted via the website. Requests are no longer accepted by fax or mail.

Q. I lost my Grant ID number, how can I locate it?
A. Please send an email with the name of the requesting organization, the amount of the request and the estimated date of grant submission to [email protected]. Biosense Webster, Inc.'s Educational Grants Coordinator will provide you this information via email.

Q. I am having trouble with Biosense Webster, Inc.'s website and cannot submit a grant request. Who can I contact to resolve this problem?
A. Please send an email to the Educational Grants Coordinator at [email protected] for help.

Q. Should I include exhibit opportunities in my grant request?
A. Exhibit opportunities are considered as sales promotion expenses and are not considered part of the educational grants. Exhibit opportunities should be sent to [email protected].

Q. Can grant funds be used with no restrictions?
A. No. All grant funds are restricted to comply with Biosense Webster, Inc.'s policies and guidelines and applicable federal and state regulations and the AdvaMed® Code. We do not provide unrestricted grants.

Q. Can I submit the reconciliation of funds as required in the LOA via the website?
A. No. Please submit the reconciliation of funds to the Grants Coordinator by email at [email protected] within 120 days of the conclusion of the program.

Click here for our California Health Care Compliance Information and AdvaMed Code.

In the US, THERMOCOOL® Navigation Catheters are indicated for the treatment of drug refractory recurrent symptomatic paroxysmal atrial fibrillation, when used with CARTO® 3 Systems (excluding NAVISTAR® RMT THERMOCOOL® Catheter).

The THERMOCOOL SMARTOUCH® SF Catheter is indicated for drug refractory recurrent symptomatic persistent atrial fibrillation (AF) (continuous AF > 7 days but < 1 year), refractory or intolerant to at least 1 Class I or III AAD, when used with the CARTO® 3 System.

In the US, THERMOCOOL® Non-Navigational Catheters are indicated for the treatment of Type I Atrial Flutter in patients 18 years of age or older.

THERMOCOOL® Navigation Catheters are indicated for the treatment of recurrent drug/device refractory sustained monomorphic ventricular tachycardia (VT) due to prior myocardial infarction (MI) in adults.

In the US, 4mm Catheters (NAVISTAR® Catheter, CELSIUS® Catheter, EZ STEER® Catheter (NAV and Non-NAV)) have a “General Indication” for creation of endocardial lesions in patients 4 years of age and older.  This “General Indication” includes treatment of Ventricular Tachycardia.

Always verify catheter tip location using fluoroscopy or IC signals and consult the CARTO® 3 System User Guide regarding recommendations for fluoroscopy use. Pellegrino, P.L., Brunetti, N.D., Gravina, D., Sacchetta, D., De Sanctis, V., Panigada, S., Di Biase, L., Di Biase, M., and Mantica, M. (2013). Nonfluoroscopic mapping reduces radiation exposure in ablation of atrial fibrillation. Journal of cardiovascular medicine 14, 528-533. Earley, M.J., Showkathali, R., Alzetani, M., Kistler, P.M., Gupta, D., Abrams, D.J., Horrocks, J.A., Harris, S.J., Sporton, S.C., and Schilling, R.J. (2006). Radiofrequency ablation of arrhythmias guided by non-fluoroscopic catheter location: a prospective randomized trial. Eur Heart J 27, 1223-1229

The CARTO VISITAG® Module provides access to data collected during the application of RF energy. The data does not indicate the effectiveness of RF energy application. CARTO VISITAG® Module settings are user defined based on the user’s clinical experience and medical judgment. Biosense Webster, Inc. does not recommend any settings for the CARTO VISITAG® Module.

The CARTO VISITAG® Module provides access to data collected during the application of RF energy. The data does not indicate the effectiveness of RF energy application. Do not use the Tag Index values generated from the VISITAG SURPOINT® EPU to guide RF energy delivery. Equivalent Tag Index values do not represent equivalent RF lesion size. The clinical utility of the Tag Index value has not been established. The Tag Index values should not be used to replace standard handling precautions or other clinically accepted endpoints for RF applications such as reduction of IC signals, impedance drop, and duration. All safety considerations, cautions, and warnings that apply to the general use of the CARTO® 3 System also apply while using this module. Users should follow the instructions for use of the compatible ablation catheters (i.e. THERMOCOOL SMARTTOUCH® Catheter and THERMOCOOL SMARTTOUCH® SF Catheter) to select ablation settings for an ablation procedure.

Use of the PENTARAY® NAV ECO High Density Mapping Catheter may not be appropriate for use in patients with prosthetic valves.

The clinical significance of utilizing the CARTO® CFAE Module to help identify areas with complex fractionated atrial electrograms for catheter ablation of atrial arrhythmias, such as atrial fibrillation, has not been established by clinical investigations.

The clinical significance of utilizing the PASO® Module to help pace mapping for catheter ablation of ventricular arrhythmias has not been demonstrated by clinical investigations.

Bertaglia E, Bella PD, Tondo C, Proclemer A, Bottoni N, De Ponti R, et al. Image integration increases efficacy of paroxysmal atrial fibrillation catheter ablation: results from the CARTOMERGE® Module Italian Registry. Europace 2009;11:1004-1010.

The third party trademarks used herein are the properties of their respective owners.

This site was last updated on February 1, 2021. 164930-210119